98%
921
2 minutes
20
Overbased sulfonate plays a crucial role in calcium sulfonate complex grease, significantly impacting the grease's performance characteristics. Herein, the calcium sulfonate complex grease was formulated using overbased calcium sulfonate (T106D) and overbased magnesium sulfonate (T107) in ratios of 1 : 2, 1 : 1, and 2 : 1, labeled as CMSCG (1 : 2), CMSCG (1 : 1), and CMSCG (2 : 1), respectively. This study examined the effects of overbased sulfonates on the physicochemical, anti-corrosion, rheological, and tribological properties of the grease. Results showed that CMSCG (1 : 2) exhibited superior physicochemical properties, with the highest dropping point (354 °C), the lowest penetration (161 (0.1 mm)), and the least oil separation (1.25%). Exposure to a salt spray environment significantly altered the grease's rheological properties. The combination of T106D and T107 enhanced the corrosion resistance of the grease, attributed to the formation of a corrosion inhibition layer. Incorporating T107 increased both the yield stress and hysteresis area of the calcium sulfonate complex grease. The CMSCG (1 : 2), CMSCG (1 : 1), and MSCG showed the high thixotropic ring area, indicating the poor thixotropy. The calcium sulfonate complex grease formulated with T107 showed the highest yield stress (558 Pa). The friction mechanism revealed that MSCG showed the optimal friction reduction properties, and CMSCG (1 : 1) demonstrated the optimal wear resistance, which are attributed to the synergistic effects of tribo-chemical films composed of CaO, CaCO, FeSO, MgCO, and iron oxide.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11488185 | PMC |
http://dx.doi.org/10.1039/d4ra04307c | DOI Listing |
G Ital Nefrol
August 2025
Unit of Nephrology and Dialysis, Department of Medicine and Surgery, University of Enna "Kore", 94100, Enna, Italy.
Hyperkalemia is a common and serious complication in dialysis patients, with increased incidence and severity over time. Newer potassium binders, patiromer and sodium zirconium cyclosilicate (SZC), offer improved tolerability compared to older agents. This meta-analysis aims to evaluate the efficacy and safety of these newer binders in dialysis patients.
View Article and Find Full Text PDFCEN Case Rep
September 2025
Department of Nephrology, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kamigyo-ku, Kyoto, Japan.
A 63-year-old woman underwent living-donor kidney transplantation three years earlier for end-stage renal disease due to diabetic nephropathy, with her younger sister as the donor. She was prescribed calcium polystyrene sulfonate for the management of hyperkalemia, which had been discontinued two years earlier. At this time, she developed recurrent abdominal and urinary symptoms, which were managed empirically with antibiotics.
View Article and Find Full Text PDFNephrology (Carlton)
September 2025
Division of Endocrinology, Metabolism, and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Aim: Sodium polystyrene sulfonate (SPS) is one of the classic potassium-binding agents that remains commonly used in the treatment of hyperkalaemia. However, the potential concern about its sodium load has not been fully investigated. In this study, we evaluated the association between SPS initiation and heart failure (HF), compared with calcium polystyrene sulfonate (CPS).
View Article and Find Full Text PDFSchweiz Arch Tierheilkd
September 2025
Department of Food Hygiene, University of Veterinary Medicine of Budapest, Hungary.
Calcium dobesilate has recently been used for treating lameness in horses because it enhances microvascular processes and reduces intraosseous pressure. Lameness caused by disorders in bone metabolism and increased intraosseous pressure, such as navicular disease, osseous cyst-like lesions and pedal bone oedema, are commonly treated with rest, anti-inflammatory agents and surgery. Calcium dobesilate has the potential to influence the pathophysiology of these diseases, thereby improving healing.
View Article and Find Full Text PDFSci Rep
September 2025
Department of Cardiology, Ningbo Medical Centre Lihuili Hospital, No.57 Xingning Road, Ningbo, 315040, Zhejiang, China.
Rosuvastatin can block human ether-a-go-go related gene (hERG) currents and prolong the corrected QT (QTc) interval, but this effect has not been confirmed in the population. This study compared the changes of QTc interval between populations receiving atorvastatin and rosuvastatin, explained the effect of rosuvastatin on QTc interval, and the correlation between rosuvastatin and QT prolongation. The QTc interval decreased by 0.
View Article and Find Full Text PDF